Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services Limited informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received a two-day suspension order for the Drug License of its store located at Bidadi Bus Stand in Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore South Circle, Ramanagar, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on March 14, 2026. The company has disclosed a potential revenue loss of approximately Rs 2.88 lakhs due to this suspension. The disclosure is being made under SEBI's Regulation 30 read with Schedule III.
The financial impact is negligible at Rs 2.88 lakhs, affecting only a single store for two days, so this is unlikely to have any meaningful effect on the stock price or overall business operations.